Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Oramed Pharma (ORMP) Prices 5.25M Share Public Offering of Common Stock at $4/sh
February 27, 2020 9:17 AM ESTOramed Pharmaceuticals Inc. (Nasdaq: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the pricing of an underwritten public offering of 5,250,000 shares of its common stock at a public offering price of $4.00 per share.... More

